A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer
Macpherson, Iain R, Spiliopoulou, Pavlina, Rafii, Saeed, Saggese, Matilde, Baird, Richard D, Garcia-Corbacho, Javier, Italiano, Antoine, Bonneterre, Jacques, Campone, Mario, Cresti, Nicola, Posner, John, Takeda, Yousuke, Arimura, Akinori, Spicer, James
Published in Breast cancer research : BCR (31.12.2019)
Published in Breast cancer research : BCR (31.12.2019)
Get full text
Journal Article
Breast Cancer in the United Arab Emirates
Al-Shamsi, Humaid O, Abdelwahed, Nadia, Al-Awadhi, Aydah, Albashir, Mohamed, Abyad, Amin M, Rafii, Saeed, Afrit, Mehdi, Al Lababidi, Bilal, Abu-Gheida, Ibrahim, Sonawane, Yoginee Pundlik, Nijhawan, Neil A, Haq, Urfan Ul, Dreier, Norbert, Joshua, Thanda Lucy Ann, Iqbal, Faryal, Yacoub, Tamer, Nawaz, Faisal A, Abdul Jabbar, Dima, Tirmazy, Syed Hammad, El-Shourbagy, Dalia M, Hamza, Dina, Omara, Mohamed, Al Madhi, Sawsan Abdul Salam, Ghazal, Hassan, Darr, Humaa, Oner, Muharrem, Vlamaki, Zoi, El Kinge, Abdul Rahman, Ramanathan, Dorai, Judah, Mohammed, Almahmeed, Taghreed, Ahmad, Mudhasir, Jonnada, Sai Babu, Almansoori, Nahla, Razek, Aly A, Al-Hamadi, Annett, Balalaa, Nahed, Jamali, Faek, Singarachari, Ramanujam Anugonda, Labban, Abdelrahman, Das, Kaltar, Luiten, Ernest J T, Abdelgawad, Tamer, Al-Khatib, Falah, Alrawi, Sadir, Jaafar, Hassan
Published in JCO global oncology (01.01.2023)
Published in JCO global oncology (01.01.2023)
Get full text
Journal Article
Safety and Efficacy of Durvalumab (MEDI4736), an Anti-Programmed Cell Death Ligand-1 Immune Checkpoint Inhibitor, in Patients With Advanced Urothelial Bladder Cancer
Massard, Christophe, Gordon, Michael S, Sharma, Sunil, Rafii, Saeed, Wainberg, Zev A, Luke, Jason, Curiel, Tyler J, Colon-Otero, Gerardo, Hamid, Omid, Sanborn, Rachel E, O'Donnell, Peter H, Drakaki, Alexandra, Tan, Winston, Kurland, John F, Rebelatto, Marlon C, Jin, Xiaoping, Blake-Haskins, John A, Gupta, Ashok, Segal, Neil H
Published in Journal of clinical oncology (10.09.2016)
Published in Journal of clinical oncology (10.09.2016)
Get full text
Journal Article
Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline BRCA1/2 Mutations and Selected Sporadic Cancers
de Bono, Johann, Ramanathan, Ramesh K, Mina, Lida, Chugh, Rashmi, Glaspy, John, Rafii, Saeed, Kaye, Stan, Sachdev, Jasgit, Heymach, John, Smith, David C, Henshaw, Joshua W, Herriott, Ashleigh, Patterson, Miranda, Curtin, Nicola J, Byers, Lauren Averett, Wainberg, Zev A
Published in Cancer discovery (01.06.2017)
Published in Cancer discovery (01.06.2017)
Get full text
Journal Article
Current Status of CRISPR/Cas9 Application in Clinical Cancer Research: Opportunities and Challenges
Rafii, Saeed, Tashkandi, Emad, Bukhari, Nedal, Al-Shamsi, Humaid O
Published in Cancers (14.02.2022)
Published in Cancers (14.02.2022)
Get full text
Journal Article
BGCS uterine cancer guidelines: Recommendations for practice
Sundar, Sudha, Balega, Janos, Crosbie, Emma, Drake, Alasdair, Edmondson, Richard, Fotopoulou, Christina, Gallos, Ioannis, Ganesan, Raji, Gupta, Janesh, Johnson, Nick, Kitson, Sarah, Mackintosh, Michelle, Martin-Hirsch, Pierre, Miles, Tracie, Rafii, Saeed, Reed, Nick, Rolland, Phil, Singh, Kavita, Sivalingam, Vanitha, Walther, Axel
Published in European journal of obstetrics & gynecology and reproductive biology (01.06.2017)
Published in European journal of obstetrics & gynecology and reproductive biology (01.06.2017)
Get full text
Journal Article
Randomized phase II trial of venetoclax + fulvestrant versus fulvestrant in estrogen receptor+, HER2– locally advanced or metastatic breast cancer following recurrence or progression during or after a CDK4/6 inhibitor: VERONICA
Lindeman, Geoffrey J, Bardia, Aditya, Bowen, Rebecca, Flechais, Aulde, Lei, Guiyuan, Hogea, Alexandra, Mobasher, Mehrdad, Rafii, Saeed
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Higher Risk of Infections with PI3K-AKT-mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials
Rafii, Saeed, Roda, Desamparados, Geuna, Elena, Jimenez, Begona, Rihawi, Karim, Capelan, Marta, Yap, Timothy A, Molife, L Rhoda, Kaye, Stanley B, de Bono, Johann S, Banerji, Udai
Published in Clinical cancer research (15.04.2015)
Published in Clinical cancer research (15.04.2015)
Get full text
Journal Article
Early neutrophil to lymphocyte ratio dynamics to predict progression free survival in patients treated with immune-checkpoint inhibitors
Moschetta, Michele, Kasenda, Benjamin, Mak, Gabriel, Voskoboynik, Mark, Martynyuk, Nataliya, Formica, Vincenzo, Rafii, Saeed, Arkenau, Hendrik-Tobias
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
BRAF +/- MEK inhibition in patients (pts) with BRAF-mutant (mut) metastatic colorectal cancer (mCRC): The Sarah Cannon Research Institute UK’s experience
Uccello, Mario, Moschetta, Michele, Mak, Gabriel, Martynyuk, Nataliya, Hauser, Joana, Bassett, Sian, Voskoboynik, Mark, Lemech, Charlotte, Rafii, Saeed, Arkenau, Hendrik-Tobias
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Clinical factors of response in patients with advanced ovarian cancer participating in early phase clinical trials
George, Angela, Kristeleit, Rebecca, Rafii, Saeed, Michie, Caroline O, Bowen, Rebecca, Michalarea, Vasiliki, van Hagen, Tom, Wong, Mabel, Rallis, Grigorios, Molife, L. Rhoda, Lopez, Juanita, Banerji, Udai, Banerjee, Susana N, Gore, Martin E, de Bono, Johann S, Kaye, Stan B, Yap, Timothy A
Published in European journal of cancer (1990) (01.05.2017)
Published in European journal of cancer (1990) (01.05.2017)
Get full text
Journal Article
Effect of multiple-dose osimertinib (AZD9291) on the pharmacokinetics (PK) of simvastatin and rosuvastatin
Harvey, R Donald, Isambert, Nicolas, Rafii, Saeed, Vansteenkiste, Johan F., Dickinson, Paul A., Bui, Khanh, Weilert, Doris, So, Karen, Thomas, Karen, Vishwanathan, Karthick
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Baseline clinical predictors of antitumor response to the PARP inhibitor olaparib in germline BRCA1/2 mutated patients with advanced ovarian cancer
Rafii, Saeed, Gourley, Charlie, Kumar, Rajiv, Geuna, Elena, Ern Ang, Joo, Rye, Tzyvia, Chen, Lee-May, Shapira-Frommer, Ronnie, Friedlander, Michael, Matulonis, Ursula, De Greve, Jacques, Oza, Amit M, Banerjee, Susana, Molife, L Rhoda, Gore, Martin E, Kaye, Stan B, Yap, Timothy A
Published in Oncotarget (18.07.2017)
Published in Oncotarget (18.07.2017)
Get full text
Journal Article
Is uterine serous carcinoma a part of hereditary breast cancer syndrome?
Rafii, Saeed, Dawson, Philip, Williams, Sarah, Pascoe, Jennifer S., Nevin, James E., Sundar, Sudha
Published in Journal of clinical oncology (20.05.2013)
Published in Journal of clinical oncology (20.05.2013)
Get full text
Journal Article
TARGET trial: Molecular profiling of circulating tumour DNA to stratify patients to early phase clinical trials
Krebs, Matthew, Dive, Caroline, Dean, Emma Jane, Rothwell, Dominic G, Brognard, John, Wallace, Andrew, Miller, Crispin, Cook, Natalie, Rafii, Saeed, Ayub, Mahmood, Leong, Hui-Sun, Siswick, Carla, Chapman, Phil, Smith, Nigel, Jordan, Allan, Hughes, Andrew M., Marais, Richard, Brady, Ged
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
A study of risk of infection with drugs targeting the PI3 kinase (PI3K), AKT, and mTOR pathway
Rafii, Saeed, Roda, Desamparados, Geuna, Elena, Jimenez Rodriguez, Begona, Rihawi, Karim, Capelan, Marta, Yap, Timothy Anthony, Kaye, Stanley B., Molife, L Rhoda, De Bono, Johann Sebastian, Banerji, Udai
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Complications of hyperglycemia in phase 1 trials targeting the PI3K-akt-mTOR (PAM) pathway
Geuna, Elena, Roda, Desamparados, Rafii, Saeed, Jimenez, Begona, Capelan, Marta, Rihawi, Karim, Yap, Timothy Anthony, Kaye, Stanley B., De Bono, Johann Sebastian, Molife, L Rhoda, Banerji, Udai
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Predictive factors of survival for patients with bladder cancer (BC) in phase I clinical trials
Michalarea, Vasiliki, Rafii, Saeed, Kumar, Rajiv, Rihawi, Karim, Toloui, Helen Nicole, Huddart, Robert Anthony, Kaye, Stanley B., De Bono, Johann Sebastian, Banerji, Udai, Molife, L Rhoda
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article